MedPath

benefits of lung ultrasound in diagnosis of respiratory distress syndrome in preterm babies

Not Applicable
Conditions
Health Condition 1: J988- Other specified respiratory disorders
Registration Number
CTRI/2024/07/070873
Lead Sponsor
Datta Meghe Institute of Higher Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All preterm neonates with gestational age < 37 weeks with respiratory distress admitted in NICU within 24 hour of life

Exclusion Criteria

Neonates who received surfactant in delivery room or in referral hospital.

Neonates with chromosomal anomalies or complex congenital malformations.

Neonates with congenital lung malformations diagnosed antenatally.

Parents denying consent for participation in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the accuracy of lung ultrasound for diagnosis of RDS & correlation of lung ultrasound score (LUS) with CPAP failure leading to surfactant administrationTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
To know the correlation of LUS with <br/ ><br>1 need for retreatment with surfactant <br/ ><br>2 oxygenation indices (Spo2/Fio2 ratio & PaCO2) <br/ ><br>3 duration of ventilation (invasive & noninvasive) <br/ ><br>4 predictability of invasive ventilation <br/ ><br>5 duration of hospital stay <br/ ><br>6 final outcomeTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath